Premier Anti-Aging Co., Ltd.
Tokyo Stock ExchangeTotal Valuation
Premier Anti-Aging Co., Ltd. carries a market capitalization of 5.49B, placing it among publicly traded companies globally. Its enterprise value stands at 5.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.49B |
| Enterprise Value | 5.23B |
Share Statistics
Premier Anti-Aging Co., Ltd. currently has 8.72M shares outstanding.
| Shares Outstanding | 8.72M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.37, and the price-to-book ratio stands at 1.59.
| PE Ratio | N/A |
| PS Ratio | 0.37 |
| PB Ratio | 1.59 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Premier Anti-Aging Co., Ltd. trades at an EV/EBITDA multiple of 37.65 and an EV/FCF ratio of 144.70. The EV/Sales ratio of 0.26 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 37.65 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.26 |
| EV / EBITDA | 37.65 |
| EV / EBIT | 37.65 |
| EV / FCF | 144.70 |
Financial Position
Premier Anti-Aging Co., Ltd. maintains a current ratio of 2.36, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 39.89, indicating elevated leverage, while an interest coverage ratio of 6.32 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.36 |
| Quick Ratio | 1.27 |
| Debt / Equity | 39.89 |
| Debt / EBITDA | 17.57 |
| Interest Coverage | 6.32 |
Financial Efficiency
| Return on Equity (ROE) | -26.98 |
| Return on Assets (ROA) | -12.82 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -23.49 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.44 |
Taxes
Over the trailing twelve months, Premier Anti-Aging Co., Ltd. has paid 581.00M in income taxes, reflecting an effective tax rate of 3.28.
| Income Tax | 581.00M |
| Effective Tax Rate | 3.28 |
Stock Price Statistics
Premier Anti-Aging Co., Ltd.'s stock has declined approximately -28.49035% over the past 52 weeks. The 50-day moving average sits at 609.06, while the 200-day moving average is 677.42.
| Beta (5Y) | N/A |
| 52-Week Price Change | -28.49035% |
| 50-Day Moving Average | 609.06 |
| 200-Day Moving Average | 677.42 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Premier Anti-Aging Co., Ltd. generated 20.36B in revenue and converted that into -1.48B in net income, yielding earnings per share of -170.06. EBITDA reached 139.00M, while operating income came in at 139.00M.
| Revenue | 20.36B |
| Gross Profit | 16.10B |
| Operating Income | 139.00M |
| Pretax Income | -902.00M |
| Net Income | -1.48B |
| EBITDA | 139.00M |
| EBIT | 139.00M |
| Earnings Per Share (EPS) | -170.06 |
Balance Sheet
Premier Anti-Aging Co., Ltd. holds 4.76B in cash and equivalents against 2.44B in total debt, resulting in a net debt position of -2.32B. Total book value stands at 4.76B, with working capital of 5.12B providing operational flexibility.
| Cash & Cash Equivalents | 4.76B |
| Total Debt | 2.44B |
| Net Debt | -2.32B |
| Equity (Book Value) | 4.76B |
| Book Value Per Share | 545.27 |
| Working Capital | 5.12B |
Margins
Premier Anti-Aging Co., Ltd. operates with a gross margin of 79.09, reflecting its pricing power and cost economics. The operating margin of 0.68 and net profit margin of -7.28 provide insight into operational efficiency.
| Gross Margin | 79.09 |
| Operating Margin | 0.68 |
| Pretax Margin | -4.43 |
| Profit Margin | -7.28 |
| EBITDA Margin | 0.68 |
Scores
Premier Anti-Aging Co., Ltd. posts an Altman Z-Score of 4.10, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.10 |